Biogen acquires TJ Biopharma's felzartamab rights in China for $850M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Biogen acquires TJ Biopharma's felzartamab rights in China for $850M
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 199.59 +2.40 (1.22%)
Previous Close $197.19    52 Week High $333.65 
Open $199.34    52 Week Low $223.02 
Day High $202.06    P/E 25.56 
Day Low $198.66    EPS $7.81 
Volume 1,349,100